Ignite Creation Date:
2024-05-06 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05132218
Status:
RECRUITING
Last Update Posted:
2021-11-24
First Post:
2021-10-26
Brief Title:
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-26
First Submit QC Date:
November 16 2021
Study First Post Date:
2021-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-16
Last Update Post Date:
2021-11-24
Last Update Post Date Type:
ACTUAL